Video Experimental Relacionado
Updated: Aug 20, 2025
10:39
Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity
Published on: June 25, 2015
12.7K
El universo de la gripe en una vacuna de ARNm
Alyson A Kelvin1,2, Darryl Falzarano1,3
1Vaccine and Infectious Disease Organization (VIDO), University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Science (New York, N.Y.)
|November 24, 2022
Resumen
Una nueva vacuna de ARN mensajero (ARNm) encapsulada en nanopartículas de lípidos protegió eficazmente a los animales contra 20 cepas diferentes del virus de la gripe. Esta amplia protección destaca el potencial de las vacunas de ARNm para la prevención generalizada de la gripe.
Área de la Ciencia:
- Vacunas y vacunas
- Virología
- Nanotecnología
Sus antecedentes:
- Los virus de la gripe representan una amenaza significativa para la salud mundial debido a su constante evolución y al potencial de pandemias.
- Las vacunas actuales contra la gripe a menudo se dirigen a cepas específicas y requieren actualizaciones anuales, lo que limita su eficacia contra cepas nuevas o derivadas.
Objetivo del estudio:
- Evaluar la eficacia de una nueva vacuna de ARN mensajero (ARNm) formulada con nanopartículas lipídicas (PNL).
- Determinar el alcance de la protección ofrecida por la vacuna de ARNm-LNP contra múltiples linajes de virus de la influenza en un modelo animal.
Principales métodos:
- Desarrollo de una vacuna de ARNm que codifique los antígenos de la gripe conservados.
- Formulación de la vacuna de ARNm en nanopartículas de lípidos para una mayor entrega y estabilidad.
- Desafiar los estudios en un modelo animal utilizando un panel de 20 cepas de virus de la gripe.
Principales resultados:
- La vacuna de nanopartículas de ARNm-lípidos demostró una protección significativa contra la mortalidad y la morbilidad en los 20 linajes de influenza probados.
- Se indujeron respuestas inmunes humoral y celular, lo que indica una respuesta inmune adaptativa robusta a la vacunación.
- La eficacia de la vacuna fue consistente en diferentes subtipos de virus de la influenza A y B.
Conclusiones:
- La tecnología de vacunas de nanopartículas de ARN mensajero ofrece una plataforma prometedora para el desarrollo de vacunas contra la influenza ampliamente protectoras.
- Este enfoque podría superar las limitaciones de las vacunas tradicionales contra la gripe estacional, proporcionando una protección más amplia y duradera.
Videos de Conceptos Relacionados
02:28Leaky Scanning
5.2K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.2K
01:29Viruses with RNA Genomes
85
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
85
01:51Vaccinations
45.2K
Overview
45.2K
02:15Experimental RNAi
6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
02:31Nuclear Export of mRNA
7.8K
Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...
7.8K
02:33Initiation of Translation
34.3K
Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
34.3K